Omnicell

JANUARY 10, 2023

Jeff Spencer Senior Director, 340B Sales and Account Management, Omnicell Since its inception 30 years ago, the 340B Drug Pricing Program has helped non-profit healthcare organizations expand services for their communities. Before 2018, the reimbursement level was Average Sales Price (ASP) was more than plus 6 percent.

Omnicell 52

Omnicell Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

Omnicell

JANUARY 10, 2023

There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. 2018: The Centers for Medicare & Medicaid Services (CMS) imposed significant Medicare Part B reimbursement cuts to 340B hospitals.

Hospitals 96

Hospitals Omnicell Insurance Documentation 96

Omnicell

SEPTEMBER 5, 2022

percent of drug industry sales, based on 2018 data , the pharmaceutical industry continues to lobby against the program. Pharma’s Challenges to 340B During July and August, several large pharmaceutical companies challenged the operation of the 340B program. Yet, while 340B discounts equate to only about 1.4

Hospitals 52

Hospitals Pharmaceutical Companies Pharmaceutical Companies Omnicell 52